Pocket proteins and cell cycle control

被引:462
作者
Cobrinik, D
机构
[1] Cornell Univ, Weill Med Coll, Dyson Vis Res Inst, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Ophthalmol, New York, NY 10021 USA
关键词
pocket proteins; pRB; p107; p130; E2F; cell cycle;
D O I
10.1038/sj.onc.1208619
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoblastoma protein ( pRB) and the pRB- related p107 and p130 comprise the 'pocket protein' family of cell cycle regulators. These proteins are best known for their roles in restraining the G1 - S transition through the regulation of E2F- responsive genes. pRB and the p107/ p130 pair are required for the repression of distinct sets of genes, potentially due to their selective interactions with E2Fs that are engaged at specific promoter elements. In addition to regulating E2F- responsive genes in a reversible manner, pocket proteins contribute to silencing of such genes in cells that are undergoing senescence or differentiation. Pocket proteins also affect the G1 - S transition through E2F- independent mechanisms, such as by inhibiting-Cdk2 or by stabilizing p27(Kip1), and they are implicated in the control of G0 exit, the spatial organization of replication, and genomic rereplication. New insights into pocket protein regulation have also been obtained. Kinases previously thought to be crucial to pocket protein phosphorylation have been shown to be redundant, and new modes of phosphorylation and dephosphorylation have been identified. Despite these advances, much remains to be learned about the pocket proteins, particularly with regard to their developmental and tumor suppressor functions. Thus continues the story of the pocket proteins and the cell cycle.
引用
收藏
页码:2796 / 2809
页数:14
相关论文
共 181 条
  • [1] Abramson D H, 1999, Ophthalmic Genet, V20, P193, DOI 10.1076/opge.20.3.193.2284
  • [2] A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells
    Ait-Si-Ali, S
    Guasconi, V
    Fritsch, L
    Yahi, H
    Sekhri, R
    Naguibneva, I
    Robin, P
    Cabon, F
    Polesskaya, A
    Harel-Bellan, A
    [J]. EMBO JOURNAL, 2004, 23 (03) : 605 - 615
  • [3] Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins
    Alevizopoulos, K
    Vlach, J
    Hennecke, S
    Amati, B
    [J]. EMBO JOURNAL, 1997, 16 (17) : 5322 - 5333
  • [4] Requirement for p27KIP1 in retinoblastoma protein-mediated senescence
    Alexander, K
    Hinds, PW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (11) : 3616 - 3631
  • [5] Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter
    Araki, K
    Nakajima, Y
    Eto, K
    Ikeda, MA
    [J]. ONCOGENE, 2003, 22 (48) : 7632 - 7641
  • [6] Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics
    Aslanian, A
    Iaquinta, PJ
    Verona, R
    Lees, JA
    [J]. GENES & DEVELOPMENT, 2004, 18 (12) : 1413 - 1422
  • [7] Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage
    Avni, D
    Yang, H
    Martelli, F
    Hofmann, F
    ElShamy, WM
    Ganesan, S
    Scully, R
    Livingston, DM
    [J]. MOLECULAR CELL, 2003, 12 (03) : 735 - 746
  • [8] Nuclear reorganization of mammalian DNA synthesis prior to cell cycle exit
    Barbie, DA
    Kudlow, BA
    Frock, R
    Zhao, JY
    Johnson, BR
    Dyson, N
    Harlow, E
    Kennedy, BK
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) : 595 - 607
  • [9] Cdk2 knockout mice are viable
    Berthet, C
    Aleem, E
    Coppola, V
    Tessarollo, L
    Kaldis, P
    [J]. CURRENT BIOLOGY, 2003, 13 (20) : 1775 - 1785
  • [10] Black EP, 2003, CANCER RES, V63, P3716